DMK PHARMACEUTICALS CORPORATION Shareholders' Equity
DMK PHARMACEUTICALS CORPORATION had Shareholders' Equity of -$5.29 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2023-11-14
- 2023-09-30: Stockholders' Equity Attributable to Parent -$5.29M.
- 2023-06-30: Stockholders' Equity Attributable to Parent -$11.83M.
- 2023-03-31: Stockholders' Equity Attributable to Parent -$9.68M.
- 2022-12-31: Stockholders' Equity Attributable to Parent -$808.07K.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2023-09-30 | -$5.29M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | -$11.83M 10-Q · filed 2023-11-14 | |
| 2023-03-31 | -$9.68M 10-Q · filed 2023-08-21 | |
| 2022-12-31 | -$808.07K 10-Q · filed 2023-11-14 | |
| 2022-09-30 | $2.85M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $7.04M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $15.90M 10-Q · filed 2023-08-21 | |
| 2021-12-31 | $25.88M 10-Q · filed 2023-11-14 | |
| 2021-09-30 | $34.47M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $46.68M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $55.19M 10-Q · filed 2022-08-10 | |
| 2020-12-31 | $5.98M 10-K · filed 2023-03-16 | $3.50M 10-K · filed 2021-04-15 |
| 2020-09-30 | $20.47M 10-Q · filed 2021-11-22 | $27.40M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $20.07M 10-Q · filed 2021-11-22 | $23.12M 10-Q · filed 2020-08-17 |
| 2020-03-31 | $31.29M 10-Q · filed 2021-11-22 | $33.22M 10-Q · filed 2020-05-18 |
| 2019-12-31 | $33.00M 10-K · filed 2022-03-31 | $36.04M 10-K · filed 2020-03-30 |
| 2019-09-30 | $40.30M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $33.81M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $39.78M 10-Q · filed 2020-08-17 | |
| 2018-12-31 | $46.69M 10-K · filed 2021-04-15 | |
| 2018-09-30 | $57.83M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $25.40M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $33.45M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | $39.55M 10-K · filed 2020-03-30 | |
| 2017-09-30 | $46.03M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $33.81M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $20.88M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $25.28M 10-K · filed 2019-03-15 | |
| 2016-09-30 | $24.76M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $15.03M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $8.70M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $9.31M 10-K · filed 2018-03-16 | |
| 2015-09-30 | $12.35M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $14.85M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $17.74M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $9.50M 10-K · filed 2017-03-30 | |
| 2014-09-30 | $12.78M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $9.66M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $12.19M 10-K · filed 2016-03-23 | |
| 2013-12-31 | $10.10M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$4.93M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | -$4.98M 10-Q · filed 2013-08-19 | |
| 2013-03-31 | -$4.33M 10-KT · filed 2015-03-26 | |
| 2012-12-31 | -$3.24M 10-Q · filed 2013-02-19 | |
| 2012-03-31 | -$2.72M 10-K · filed 2014-06-23 |